Literature DB >> 19026502

New proposal for the staging of nonalcoholic steatohepatitis: evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI.

Natsuko Tsuda1, Masahiro Okada, Takamichi Murakami.   

Abstract

PURPOSE: We investigated whether the gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced MRI was useful for nonalcoholic steatohepatitis (NASH) staging based on the severity of liver fibrosis.
MATERIALS AND METHODS: Twenty-one male Sprague-Dawley rats aged 7 weeks, weighing about 150g in NASH group were fed a choline-deficient diet for 4, 7 or 10 weeks, and seven rats in the control group were fed a standard diet (n=7). After the feeding period, the rats were subjected to contrast-enhanced MRI (2D-FLASH; TR/TE=101/2.9ms, flip angle 90 degrees ). Gd-DTPA (0.1mmol Gd/kg) and Gd-EOB-DTPA (0.025mmol Gd/kg) were injected at 24-h intervals, and the speed of contrast injection was 1mL/s. Signal intensities of the liver were measured and the relative enhancement (RE), the time of maximum RE (T(max)) and elimination half-life of RE (T(1/2)) in the liver were compared. The fibrosis rate (%) was calculated with the following formula: fibrosis/whole areax100.
RESULTS: The fibrosis rates of each group were as follows: 0.52, 0.79, 2.84, and 0.50% (4, 7, 10 weeks and control groups). The fibrosis rate of the 10 weeks group was significantly higher than the control and 4 or 7 weeks groups. Although there was no difference between the T(max) and T(1/2) of each group after Gd-DTPA injection, the T(max) and T(1/2) of the 10 weeks group were significantly prolonged in comparison with the control and 4 or 7 weeks groups after Gd-EOB-DTPA injection (p<0.01). There was a significant correlation between the fibrosis rate and T(max) or T(1/2) after Gd-EOB-DTPA injection (r=0.90 or 0.97).
CONCLUSION: It was possible to assess the progress of liver fibrosis in NASH by evaluating the signal intensity-time course on Gd-EOB-DTPA-enhanced MRI. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19026502     DOI: 10.1016/j.ejrad.2008.09.036

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  21 in total

1.  Signal profile on Gd-EOB-DTPA-enhanced MR imaging in non-alcoholic steatohepatitis and liver cirrhosis induced in rats: correlation with transporter expression.

Authors:  Natsuko Tsuda; Osamu Matsui
Journal:  Eur Radiol       Date:  2011-08-11       Impact factor: 5.315

Review 2.  [New developments in MRI of the liver].

Authors:  N Bastati-Huber; H Prosch; S Baroud; S Magnaldi; W Schima; A Ba-Ssalamah
Journal:  Radiologe       Date:  2011-08       Impact factor: 0.635

3.  Imaging of focal nodular hyperplastic-like nodules in alcoholic liver cirrhosis patients using gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid magnetic resonance imaging.

Authors:  Hisamitsu Miyaaki; Tatsuki Ichikawa; Naota Taura; Satoshi Miuma; Makiko Kawaguchi; Ryota Kohno; Hajime Isomoto; Fuminao Takeshima; Osamu Nakashima; Kazuhiko Nakao
Journal:  Clin J Gastroenterol       Date:  2011-07-14

4.  Quantifying differences in hepatic uptake of the liver specific contrast agents Gd-EOB-DTPA and Gd-BOPTA: a pilot study.

Authors:  O Dahlqvist Leinhard; N Dahlström; J Kihlberg; P Sandström; T B Brismar; O Smedby; P Lundberg
Journal:  Eur Radiol       Date:  2011-10-09       Impact factor: 5.315

Review 5.  Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel.

Authors:  Jeanne M Horowitz; Sudhakar K Venkatesh; Richard L Ehman; Kartik Jhaveri; Patrick Kamath; Michael A Ohliger; Anthony E Samir; Alvin C Silva; Bachir Taouli; Michael S Torbenson; Michael L Wells; Benjamin Yeh; Frank H Miller
Journal:  Abdom Radiol (NY)       Date:  2017-08

6.  Histogram analysis of hepatobiliary phase MR imaging as a quantitative value for liver cirrhosis: preliminary observations.

Authors:  Jin-Young Choi; Honsoul Kim; Mark Sun; Claude B Sirlin
Journal:  Yonsei Med J       Date:  2014-04-01       Impact factor: 2.759

7.  Usefulness of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging in assessment of non-alcoholic fatty liver disease.

Authors:  Ying Ding; Sheng-Xiang Rao; Tao Meng; Caizhong Chen; Renchen Li; Meng-Su Zeng
Journal:  Eur Radiol       Date:  2014-01-26       Impact factor: 5.315

8.  Comparison of the effect of region-of-interest methods using gadoxetic acid-enhanced MR imaging with diffusion-weighted imaging on staging hepatic fibrosis.

Authors:  Ying Ding; Shengxiang Rao; Li Yang; Caizhong Chen; Mengsu Zeng
Journal:  Radiol Med       Date:  2016-07-23       Impact factor: 3.469

9.  Separation of advanced from mild hepatic fibrosis by quantification of the hepatobiliary uptake of Gd-EOB-DTPA.

Authors:  Bengt Norén; Mikael Fredrik Forsgren; Olof Dahlqvist Leinhard; Nils Dahlström; Johan Kihlberg; Thobias Romu; Stergios Kechagias; Sven Almer; Örjan Smedby; Peter Lundberg
Journal:  Eur Radiol       Date:  2012-07-27       Impact factor: 5.315

Review 10.  Current Modalities for the Assessment of Future Remnant Liver Function.

Authors:  Fadi Rassam; Pim B Olthof; Roelof J Bennink; Thomas M van Gulik
Journal:  Visc Med       Date:  2017-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.